LPKF Laser & Electronics SE

LPKF Laser & Electronics SE: Dr. Klaus Fiedler, Acceptance of 116,667 share options (exercise price € 8.08) under the Performance Stock Option Plan (Management Board) 2024. The exercisability …

LPKF Laser & Electronics SE: Christian Witt, Acceptance of 112,500 share options (exercise price € 8.08) under the Performance Stock Option Plan (Management Board) 2024. The exercisability of …

Chipmakers must improve the performance of their products – LPKF has the solution

LPKF makes a solid start to the 2024 financial year

LPKF extends contract of CEO Klaus Fiedler until 2028

LPKF Laser & Electronics SE: Bekanntmachung der Einberufung zur Hauptversammlung am 05.06.2024 in Garbsen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

LPKF reports strategic successes and narrowly achieves forecast for 2023 financial year

LPKF receives major customer order in solar

ARRALYZE® Launches CellShepherd®: A Fully Autonomous Single-Cell Platform For Real-Time Monitoring Of Functional Assays

Release of a capital market information

Release of a capital market information

LPKF: Business development in the third quarter gains significant momentum

LPKF remains on track in the first half of 2023

LPKF moves ARRALYZE into BioLabs Boston

LPKF Laser & Electronics SE: Dr. Klaus Fiedler, buy

LPKF Laser & Electronics SE: Strong order book in first quarter supports growth trajectory

LPKF Laser & Electronics SE: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2023 in HCC Hannover mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

LPKF Laser & Electronics SE: Jean-Michel Richard, buy

LPKF Laser & Electronics SE: LPKF significantly increases revenue and earnings in the 2022 financial year